FDA approves first cell-based gene therapy for beta-thalassemia
Reducing alcohol consumption by working out
23 August 2022Which teens are more likely to vape? Research shows surprising patterns across race and sexuality groups
23 August 2022FDA approves first cell-based gene therapy for beta-thalassemia
The U.S. Food and Drug Administration has approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions.
